This is a Validated Antibody Database (VAD) review about chimpanzee CD3D, based on 18 published articles (read how Labome selects the articles), using CD3D antibody in all methods. It is aimed to help Labome visitors find the most suited CD3D antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Invitrogen
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s1a
Invitrogen CD3D antibody (eBioscience, 17-0036-42) was used in flow cytometry on human samples (fig s1a). BMC Cancer (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3f, 3g
Invitrogen CD3D antibody (Invitrogen, SK7) was used in flow cytometry on human samples (fig 3f, 3g). Brain Pathol (2020) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD3D antibody (eBioscience, 45-0036) was used in flow cytometry on human samples (fig 1a). Cell (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s18b
Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig s18b). Science (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize the periferal blood lymphocytes phenotype in tacrolimus-treated liver transplanted patients., Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig 1a). Med Princ Pract (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1b
In order to investigate the role of Eomes in the retention of liver natural killer cells, Invitrogen CD3D antibody (eBiosciences, SK7) was used in flow cytometry on human samples (fig 1b). J Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, Invitrogen CD3D antibody (eBiosciences, SK7) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig S1
In order to study chronic hepatitis C virus infections and the functional dichotomy of V-delta2 gamma-delta T cells and their role in cytotoxicity and not IFN-gamma production, Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig S1). Sci Rep (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
In order to determine the proportions, phenotype, survival, and apoptotic susceptibility of Tregs in sarcoidosis, Invitrogen CD3D antibody (eBiosciences, SK7) was used in flow cytometry on human samples . Respir Res (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; tbl 1
Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples (tbl 1). J Immunol (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3D antibody (e-Bioscience, SK7) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3D antibody (eBioscience, SK7) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
BioLegend
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD3D antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
Articles Reviewed
  1. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed publisher
  2. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed publisher
  3. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed publisher
  4. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
  5. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed publisher
  6. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed publisher
  7. Kim J, Kwon C, Joh J, Sinn D, Choi G, Park J, et al. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients. Med Princ Pract. 2017;26:221-228 pubmed publisher
  8. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  9. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  10. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed publisher
  11. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed publisher
  12. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher
  13. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  14. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  15. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed publisher
  16. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed publisher
  17. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed publisher
  18. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher